Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Published Online: 2010-08-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Clifford A Brass•David Pound•Eirum Chaudhri•Eric J Lawitz•Eugene R Schiff•Frank H Anderson•Ira M Jacobson•Janice K Albrecht•John M Vierling•Jonathan McCone•Joseph S Galati•Kenneth Koury•Lisa D Pedicone•Lorenzo Rossaro•Mitchell N Davis•Natarajan Ravendhran•Paul Y Kwo•Raymond Rubin•Stuart C Gordon
